The global Next-Generation Immunology Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Next-Generation Immunology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Immunology Drugs.

Report Scope

The Next-Generation Immunology Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next-Generation Immunology Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Next-Generation Immunology Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Next-Generation Immunology Drugs Market Report

Report Metric	Details
Report Name	Next-Generation Immunology Drugs Market
CAGR	5%
Segment by Type	Cell Therapy Small Molecule Drug Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer Inc, Abbvie Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd., Amgen Inc., Novartis AG, Astellas Pharma Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Eli Lilly and Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next-Generation Immunology Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Next-Generation Immunology Drugs Market report?

Ans: The main players in the Next-Generation Immunology Drugs Market are Pfizer Inc, Abbvie Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd., Amgen Inc., Novartis AG, Astellas Pharma Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Eli Lilly and Company

What are the Application segmentation covered in the Next-Generation Immunology Drugs Market report?

Ans: The Applications covered in the Next-Generation Immunology Drugs Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Next-Generation Immunology Drugs Market report?

Ans: The Types covered in the Next-Generation Immunology Drugs Market report are Cell Therapy, Small Molecule Drug, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Next-Generation Immunology Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Cell Therapy

1.2.3 Small Molecule Drug

1.2.4 Others

1.3 Market by Application

1.3.1 Global Next-Generation Immunology Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Next-Generation Immunology Drugs Market Perspective (2019-2030)

2.2 Next-Generation Immunology Drugs Growth Trends by Region

2.2.1 Global Next-Generation Immunology Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Next-Generation Immunology Drugs Historic Market Size by Region (2019-2024)

2.2.3 Next-Generation Immunology Drugs Forecasted Market Size by Region (2025-2030)

2.3 Next-Generation Immunology Drugs Market Dynamics

2.3.1 Next-Generation Immunology Drugs Industry Trends

2.3.2 Next-Generation Immunology Drugs Market Drivers

2.3.3 Next-Generation Immunology Drugs Market Challenges

2.3.4 Next-Generation Immunology Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Next-Generation Immunology Drugs Players by Revenue

3.1.1 Global Top Next-Generation Immunology Drugs Players by Revenue (2019-2024)

3.1.2 Global Next-Generation Immunology Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Next-Generation Immunology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Next-Generation Immunology Drugs Revenue

3.4 Global Next-Generation Immunology Drugs Market Concentration Ratio

3.4.1 Global Next-Generation Immunology Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Immunology Drugs Revenue in 2023

3.5 Next-Generation Immunology Drugs Key Players Head office and Area Served

3.6 Key Players Next-Generation Immunology Drugs Product Solution and Service

3.7 Date of Enter into Next-Generation Immunology Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Next-Generation Immunology Drugs Breakdown Data by Type

4.1 Global Next-Generation Immunology Drugs Historic Market Size by Type (2019-2024)

4.2 Global Next-Generation Immunology Drugs Forecasted Market Size by Type (2025-2030)

5 Next-Generation Immunology Drugs Breakdown Data by Application

5.1 Global Next-Generation Immunology Drugs Historic Market Size by Application (2019-2024)

5.2 Global Next-Generation Immunology Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Next-Generation Immunology Drugs Market Size (2019-2030)

6.2 North America Next-Generation Immunology Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Next-Generation Immunology Drugs Market Size by Country (2019-2024)

6.4 North America Next-Generation Immunology Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Next-Generation Immunology Drugs Market Size (2019-2030)

7.2 Europe Next-Generation Immunology Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Next-Generation Immunology Drugs Market Size by Country (2019-2024)

7.4 Europe Next-Generation Immunology Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Next-Generation Immunology Drugs Market Size (2019-2030)

8.2 Asia-Pacific Next-Generation Immunology Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Next-Generation Immunology Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Next-Generation Immunology Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Next-Generation Immunology Drugs Market Size (2019-2030)

9.2 Latin America Next-Generation Immunology Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Next-Generation Immunology Drugs Market Size by Country (2019-2024)

9.4 Latin America Next-Generation Immunology Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Next-Generation Immunology Drugs Market Size (2019-2030)

10.2 Middle East & Africa Next-Generation Immunology Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Next-Generation Immunology Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Next-Generation Immunology Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer Inc

11.1.1 Pfizer Inc Company Detail

11.1.2 Pfizer Inc Business Overview

11.1.3 Pfizer Inc Next-Generation Immunology Drugs Introduction

11.1.4 Pfizer Inc Revenue in Next-Generation Immunology Drugs Business (2019-2024)

11.1.5 Pfizer Inc Recent Development

11.2 Abbvie Inc.

11.2.1 Abbvie Inc. Company Detail

11.2.2 Abbvie Inc. Business Overview

11.2.3 Abbvie Inc. Next-Generation Immunology Drugs Introduction

11.2.4 Abbvie Inc. Revenue in Next-Generation Immunology Drugs Business (2019-2024)

11.2.5 Abbvie Inc. Recent Development

11.3 Johnson and Johnson

11.3.1 Johnson and Johnson Company Detail

11.3.2 Johnson and Johnson Business Overview

11.3.3 Johnson and Johnson Next-Generation Immunology Drugs Introduction

11.3.4 Johnson and Johnson Revenue in Next-Generation Immunology Drugs Business (2019-2024)

11.3.5 Johnson and Johnson Recent Development

11.4 F. Hoffmann-La Roche Ltd.

11.4.1 F. Hoffmann-La Roche Ltd. Company Detail

11.4.2 F. Hoffmann-La Roche Ltd. Business Overview

11.4.3 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Introduction

11.4.4 F. Hoffmann-La Roche Ltd. Revenue in Next-Generation Immunology Drugs Business (2019-2024)

11.4.5 F. Hoffmann-La Roche Ltd. Recent Development

11.5 Amgen Inc.

11.5.1 Amgen Inc. Company Detail

11.5.2 Amgen Inc. Business Overview

11.5.3 Amgen Inc. Next-Generation Immunology Drugs Introduction

11.5.4 Amgen Inc. Revenue in Next-Generation Immunology Drugs Business (2019-2024)

11.5.5 Amgen Inc. Recent Development

11.6 Novartis AG

11.6.1 Novartis AG Company Detail

11.6.2 Novartis AG Business Overview

11.6.3 Novartis AG Next-Generation Immunology Drugs Introduction

11.6.4 Novartis AG Revenue in Next-Generation Immunology Drugs Business (2019-2024)

11.6.5 Novartis AG Recent Development

11.7 Astellas Pharma Inc.

11.7.1 Astellas Pharma Inc. Company Detail

11.7.2 Astellas Pharma Inc. Business Overview

11.7.3 Astellas Pharma Inc. Next-Generation Immunology Drugs Introduction

11.7.4 Astellas Pharma Inc. Revenue in Next-Generation Immunology Drugs Business (2019-2024)

11.7.5 Astellas Pharma Inc. Recent Development

11.8 Bristol-Myers Squibb Company

11.8.1 Bristol-Myers Squibb Company Company Detail

11.8.2 Bristol-Myers Squibb Company Business Overview

11.8.3 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Introduction

11.8.4 Bristol-Myers Squibb Company Revenue in Next-Generation Immunology Drugs Business (2019-2024)

11.8.5 Bristol-Myers Squibb Company Recent Development

11.9 Merck & Co., Inc.

11.9.1 Merck & Co., Inc. Company Detail

11.9.2 Merck & Co., Inc. Business Overview

11.9.3 Merck & Co., Inc. Next-Generation Immunology Drugs Introduction

11.9.4 Merck & Co., Inc. Revenue in Next-Generation Immunology Drugs Business (2019-2024)

11.9.5 Merck & Co., Inc. Recent Development

11.10 Eli Lilly and Company

11.10.1 Eli Lilly and Company Company Detail

11.10.2 Eli Lilly and Company Business Overview

11.10.3 Eli Lilly and Company Next-Generation Immunology Drugs Introduction

11.10.4 Eli Lilly and Company Revenue in Next-Generation Immunology Drugs Business (2019-2024)

11.10.5 Eli Lilly and Company Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pfizer Inc

AbbVie

Johnson and Johnson

F Hoffmann La Roche Ltd

Amgen Inc

Novartis

Astellas Pharma Inc

Bristol Myers Squibb Company

Merck& Co. Inc

Eli Lilly and Company

List of Tables

Table 1. Global Next-Generation Immunology Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Cell Therapy

Table 3. Key Players of Small Molecule Drug

Table 4. Key Players of Others

Table 5. Global Next-Generation Immunology Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Next-Generation Immunology Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Next-Generation Immunology Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Next-Generation Immunology Drugs Market Share by Region (2019-2024)

Table 9. Global Next-Generation Immunology Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Next-Generation Immunology Drugs Market Share by Region (2025-2030)

Table 11. Next-Generation Immunology Drugs Market Trends

Table 12. Next-Generation Immunology Drugs Market Drivers

Table 13. Next-Generation Immunology Drugs Market Challenges

Table 14. Next-Generation Immunology Drugs Market Restraints

Table 15. Global Next-Generation Immunology Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Next-Generation Immunology Drugs Market Share by Players (2019-2024)

Table 17. Global Top Next-Generation Immunology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Immunology Drugs as of 2023)

Table 18. Ranking of Global Top Next-Generation Immunology Drugs Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Next-Generation Immunology Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Next-Generation Immunology Drugs Product Solution and Service

Table 22. Date of Enter into Next-Generation Immunology Drugs Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Next-Generation Immunology Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Next-Generation Immunology Drugs Revenue Market Share by Type (2019-2024)

Table 26. Global Next-Generation Immunology Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Next-Generation Immunology Drugs Revenue Market Share by Type (2025-2030)

Table 28. Global Next-Generation Immunology Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Next-Generation Immunology Drugs Revenue Market Share by Application (2019-2024)

Table 30. Global Next-Generation Immunology Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Next-Generation Immunology Drugs Revenue Market Share by Application (2025-2030)

Table 32. North America Next-Generation Immunology Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Next-Generation Immunology Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Next-Generation Immunology Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Next-Generation Immunology Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Next-Generation Immunology Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Next-Generation Immunology Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Next-Generation Immunology Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Next-Generation Immunology Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Next-Generation Immunology Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Next-Generation Immunology Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Next-Generation Immunology Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Next-Generation Immunology Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Next-Generation Immunology Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Next-Generation Immunology Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Next-Generation Immunology Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 47. Pfizer Inc Company Detail

Table 48. Pfizer Inc Business Overview

Table 49. Pfizer Inc Next-Generation Immunology Drugs Product

Table 50. Pfizer Inc Revenue in Next-Generation Immunology Drugs Business (2019-2024) & (US$ Million)

Table 51. Pfizer Inc Recent Development

Table 52. Abbvie Inc. Company Detail

Table 53. Abbvie Inc. Business Overview

Table 54. Abbvie Inc. Next-Generation Immunology Drugs Product

Table 55. Abbvie Inc. Revenue in Next-Generation Immunology Drugs Business (2019-2024) & (US$ Million)

Table 56. Abbvie Inc. Recent Development

Table 57. Johnson and Johnson Company Detail

Table 58. Johnson and Johnson Business Overview

Table 59. Johnson and Johnson Next-Generation Immunology Drugs Product

Table 60. Johnson and Johnson Revenue in Next-Generation Immunology Drugs Business (2019-2024) & (US$ Million)

Table 61. Johnson and Johnson Recent Development

Table 62. F. Hoffmann-La Roche Ltd. Company Detail

Table 63. F. Hoffmann-La Roche Ltd. Business Overview

Table 64. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Product

Table 65. F. Hoffmann-La Roche Ltd. Revenue in Next-Generation Immunology Drugs Business (2019-2024) & (US$ Million)

Table 66. F. Hoffmann-La Roche Ltd. Recent Development

Table 67. Amgen Inc. Company Detail

Table 68. Amgen Inc. Business Overview

Table 69. Amgen Inc. Next-Generation Immunology Drugs Product

Table 70. Amgen Inc. Revenue in Next-Generation Immunology Drugs Business (2019-2024) & (US$ Million)

Table 71. Amgen Inc. Recent Development

Table 72. Novartis AG Company Detail

Table 73. Novartis AG Business Overview

Table 74. Novartis AG Next-Generation Immunology Drugs Product

Table 75. Novartis AG Revenue in Next-Generation Immunology Drugs Business (2019-2024) & (US$ Million)

Table 76. Novartis AG Recent Development

Table 77. Astellas Pharma Inc. Company Detail

Table 78. Astellas Pharma Inc. Business Overview

Table 79. Astellas Pharma Inc. Next-Generation Immunology Drugs Product

Table 80. Astellas Pharma Inc. Revenue in Next-Generation Immunology Drugs Business (2019-2024) & (US$ Million)

Table 81. Astellas Pharma Inc. Recent Development

Table 82. Bristol-Myers Squibb Company Company Detail

Table 83. Bristol-Myers Squibb Company Business Overview

Table 84. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Product

Table 85. Bristol-Myers Squibb Company Revenue in Next-Generation Immunology Drugs Business (2019-2024) & (US$ Million)

Table 86. Bristol-Myers Squibb Company Recent Development

Table 87. Merck & Co., Inc. Company Detail

Table 88. Merck & Co., Inc. Business Overview

Table 89. Merck & Co., Inc. Next-Generation Immunology Drugs Product

Table 90. Merck & Co., Inc. Revenue in Next-Generation Immunology Drugs Business (2019-2024) & (US$ Million)

Table 91. Merck & Co., Inc. Recent Development

Table 92. Eli Lilly and Company Company Detail

Table 93. Eli Lilly and Company Business Overview

Table 94. Eli Lilly and Company Next-Generation Immunology Drugs Product

Table 95. Eli Lilly and Company Revenue in Next-Generation Immunology Drugs Business (2019-2024) & (US$ Million)

Table 96. Eli Lilly and Company Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Next-Generation Immunology Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Next-Generation Immunology Drugs Market Share by Type: 2023 VS 2030

Figure 3. Cell Therapy Features

Figure 4. Small Molecule Drug Features

Figure 5. Others Features

Figure 6. Global Next-Generation Immunology Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Next-Generation Immunology Drugs Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Next-Generation Immunology Drugs Report Years Considered

Figure 12. Global Next-Generation Immunology Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Next-Generation Immunology Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Next-Generation Immunology Drugs Market Share by Region: 2023 VS 2030

Figure 15. Global Next-Generation Immunology Drugs Market Share by Players in 2023

Figure 16. Global Top Next-Generation Immunology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Immunology Drugs as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Next-Generation Immunology Drugs Revenue in 2023

Figure 18. North America Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Next-Generation Immunology Drugs Market Share by Country (2019-2030)

Figure 20. United States Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Next-Generation Immunology Drugs Market Share by Country (2019-2030)

Figure 24. Germany Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Next-Generation Immunology Drugs Market Share by Region (2019-2030)

Figure 32. China Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Next-Generation Immunology Drugs Market Share by Country (2019-2030)

Figure 40. Mexico Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Next-Generation Immunology Drugs Market Share by Country (2019-2030)

Figure 44. Turkey Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Next-Generation Immunology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Pfizer Inc Revenue Growth Rate in Next-Generation Immunology Drugs Business (2019-2024)

Figure 47. Abbvie Inc. Revenue Growth Rate in Next-Generation Immunology Drugs Business (2019-2024)

Figure 48. Johnson and Johnson Revenue Growth Rate in Next-Generation Immunology Drugs Business (2019-2024)

Figure 49. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Next-Generation Immunology Drugs Business (2019-2024)

Figure 50. Amgen Inc. Revenue Growth Rate in Next-Generation Immunology Drugs Business (2019-2024)

Figure 51. Novartis AG Revenue Growth Rate in Next-Generation Immunology Drugs Business (2019-2024)

Figure 52. Astellas Pharma Inc. Revenue Growth Rate in Next-Generation Immunology Drugs Business (2019-2024)

Figure 53. Bristol-Myers Squibb Company Revenue Growth Rate in Next-Generation Immunology Drugs Business (2019-2024)

Figure 54. Merck & Co., Inc. Revenue Growth Rate in Next-Generation Immunology Drugs Business (2019-2024)

Figure 55. Eli Lilly and Company Revenue Growth Rate in Next-Generation Immunology Drugs Business (2019-2024)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-26V13549

Mon Nov 11 00:00:00 UTC 2024

Add to Cart

Pharmaceutical Grade Sodium Hyaluronate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-17N14065

Mon Nov 11 00:00:00 UTC 2024

Add to Cart

Pharmaceutical Fluid Bed System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-6Q14792

Fri Nov 08 00:00:00 UTC 2024

Add to Cart

Medical Microbial Incubators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-30W13258

Thu Nov 07 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Next-Generation Immunology Drugs Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-16B14214

Global Next-Generation Immunology Drugs Market Research Report 2024

FEATURED COMPANIES

Next-Generation Immunology Drugs Market Size

Next-Generation Immunology Drugs Market

Report Scope

Scope of Next-Generation Immunology Drugs Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Next-Generation Immunology Drugs Market report?

What are the Application segmentation covered in the Next-Generation Immunology Drugs Market report?

What are the Type segmentation covered in the Next-Generation Immunology Drugs Market report?

FEATURED COMPANIES

RELATED REPORTS